Rice Hall James & Associates’s Monotype Imaging Holdings Inc. TYPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-86,974
Closed -$1.95M 319
2018
Q1
$1.95M Sell
86,974
-79,919
-48% -$1.92M 0.08% 188
2017
Q4
$4.02M Buy
166,893
+28,702
+21% +$673K 0.16% 115
2017
Q3
$2.66M Sell
138,191
-4,990
-3% -$93.4K 0.12% 148
2017
Q2
$2.62M Buy
143,181
+27,599
+24% +$540K 0.11% 142
2017
Q1
$2.32M Buy
115,582
+2,943
+3% +$61.5K 0.11% 165
2016
Q4
$2.24M Sell
112,639
-2,063
-2% -$41.6K 0.11% 166
2016
Q3
$2.54M Buy
114,702
+12,109
+12% +$264K 0.13% 145
2016
Q2
$2.53M Buy
102,593
+1,344
+1% +$31.3K 0.15% 128
2016
Q1
$2.42M Buy
101,249
+2,133
+2% +$49.7K 0.14% 137
2015
Q4
$2.34M Buy
99,116
+39,899
+67% +$979K 0.13% 149
2015
Q3
$1.29M Buy
59,217
+10,371
+21% +$238K 0.08% 219
2015
Q2
$1.18M Sell
48,846
-4,883
-9% -$138K 0.07% 241
2015
Q1
$1.75M Buy
+53,729
New +$1.66M 0.1% 207

Other funds holding TYPE

Rice Hall James & Associates's TYPE Position: Q2 2018 in Review

Rice Hall James & Associates sold out of Monotype Imaging Holdings Inc. (TYPE) in Q2 2018, closing a stake of 86,974 shares — an estimated $1.95M sold.

Rice Hall James & Associates first reported a position in TYPE in Q1 2015 and held it in 13 quarters. The position peaked at $4.02M in Q4 2017. 143 funds tracked by Wall St. Rank hold TYPE as of Q2 2018.

  • Rice Hall James & Associates reported no remaining Monotype Imaging Holdings Inc. position as of Q2 2018 after selling out during the quarter.
  • Rice Hall James & Associates sold 86,974 Monotype Imaging Holdings Inc. shares in Q2 2018, an estimated $1.95M.
  • Rice Hall James & Associates first reported a position in Monotype Imaging Holdings Inc. in Q1 2015 and held it in 13 quarters.
  • Rice Hall James & Associates's Monotype Imaging Holdings Inc. position peaked at $4.02M in Q4 2017.
  • 143 funds tracked by Wall St. Rank held Monotype Imaging Holdings Inc. as of Q2 2018.

Based on Rice Hall James & Associates's 13F filing for Q2 2018, filed 2 Aug 2018.